• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Holdings

Event Tracking

Nov22
Hengrui Medicine Signs Cooperation Agreement with Hong Kong Greater China Cancer Foundation
04:47
Nov21
Hengrui Medicine's SHR-1139 Injection Receives Clinical Trial Approval
10:28
Hengrui Medicine Receives Approval Notice for Multiple Drug Clinical Trials
10:28
Nov20
Hengrui Medicine Repurchased 209,900 A-shares for 12.7432 Million Yuan
08:38
Nov17
Hengrui Medicine 9 Drugs Approved for Clinical Trials
08:15
Hengrui Medicine's Taliglucerase Injection Receives Clinical Trial Approval from National Medical Products Administration
08:15
Terms & Conditions
  • Terms of Service
  • Privacy Policy